×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Avidity Biosciences Inc. (RNA) NASDAQ

$39.96 1.60 (4.17%)

Market Cap: $3.67B

As of 06/13/24 04:00 PM EDT. Market closed.

(RNA)

Avidity Biosciences Inc. (RNA)
NASDAQ

$39.96
1.60 (4.17%)

Market Cap: $3.67B

As of 06/13/24 04:00 PM EDT. Market closed.

Add to Portfolio

avidity biosciences is pioneering a new class of precision medicines – antibody-sirna conjugates (asc™) – to deliver nucleic acid therapeutics against genetic drivers of disease. our ascs have drug-like properties similar to antibodies and antibody-drug conjugates. importantly, their unique sirna-based “payloads” permit selective targeting of disease-associated mrnas against virtually ... read more

COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
CEO
Sarah Boyce
Full Time Employees
199
URL
Address
10578 Science Center Drive, Suite 125, CA, San Diego, 92121.
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
CEO
Sarah Boyce
Full Time Employees
199
Address
10578 Science Center Drive, Suite 125, CA, San Diego, 92121.
PRICE CHART FOR AVIDITY BIOSCIENCES INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$37.87
Previous Close
$38.36
Days Range
$34.51 - $39.20
52 week range
$4.83 - $39.25
Volume
2,814,705
Avg. Volume (30 days)
1,504,236
Market Cap
$3.67B
Dividend Yield
-
P/E
(16.04)
Shares Outstanding
95,636,748
Open
$37.87
Previous Close
$38.36
Days Range
$34.51 - $39.20
52 week range
$4.83 - $39.25
Volume
2,814,705
Avg. Volume (30 days)
1,504,236
Market Cap
$3.67B
Dividend Yield
-
P/E
(16.04)
Shares Outstanding
95,636,748
FINANCIAL STATEMENTS FOR AVIDITY BIOSCIENCES INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR AVIDITY BIOSCIENCES INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Boyce SarahPresident and CEOJun 04, 2024 Option Exercise$1.2428,00034,720140,117Jun 05, 2024, 05:46 PM
Boyce SarahPresident and CEOJun 04, 2024 Sale$27.4228,000767,780112,117Jun 05, 2024, 05:46 PM
LEVIN ARTHUR ADirectorMay 20, 2024 Option Exercise$1.245,0006,20019,830May 21, 2024, 05:05 PM
LEVIN ARTHUR ADirectorMay 20, 2024 Sale$29.905,000149,48114,830May 21, 2024, 05:05 PM
MacLean Michael FChief Financial OfficerMay 14, 2024 Option Exercise$8.8275,000661,500119,093May 16, 2024, 06:25 PM
MacLean Michael FChief Financial OfficerMay 14, 2024 Sale$28.2875,0002,121,04544,093May 16, 2024, 06:25 PM
Boyce SarahPresident and CEOMay 07, 2024 Option Exercise$1.2428,00034,720140,117May 07, 2024, 09:52 PM
Boyce SarahPresident and CEOMay 07, 2024 Sale$25.5428,000715,050112,117May 07, 2024, 09:52 PM
LEVIN ARTHUR ADirectorApr 19, 2024 Option Exercise$1.245,0006,20019,830Apr 22, 2024, 05:28 PM
LEVIN ARTHUR ADirectorApr 19, 2024 Sale$22.825,000114,12314,830Apr 22, 2024, 05:28 PM
LEVIN ARTHUR ADirectorApr 03, 2024 Sale$27.1120,000542,214253,872Apr 03, 2024, 08:26 PM
Boyce SarahPresident and CEOApr 02, 2024 Option Exercise$1.2428,00034,720140,117Apr 03, 2024, 06:16 PM
Boyce SarahPresident and CEOApr 02, 2024 Sale$26.2528,000734,919112,117Apr 03, 2024, 06:16 PM
LEVIN ARTHUR ADirectorMar 19, 2024 Option Exercise$1.245,0006,20019,830Mar 21, 2024, 04:10 PM
LEVIN ARTHUR ADirectorMar 19, 2024 Sale$23.975,000119,84714,830Mar 21, 2024, 04:10 PM
MacLean Michael FChief Financial OfficerMar 13, 2024 Option Exercise$8.8240,000352,80084,093Mar 15, 2024, 04:12 PM
MacLean Michael FChief Financial OfficerMar 13, 2024 Sale$24.5240,000980,76044,093Mar 15, 2024, 04:12 PM
LEVIN ARTHUR ADirectorMar 12, 2024 Option Exercise$1.2425,00031,00042,471Mar 12, 2024, 08:41 PM
LEVIN ARTHUR ADirectorMar 12, 2024 Sale$22.0327,641609,01717,471Mar 12, 2024, 08:41 PM
Boyce SarahPresident and CEOMar 08, 2024 Option Exercise$1.2484,000104,160196,117Mar 12, 2024, 05:29 PM
Boyce SarahPresident and CEOMar 12, 2024 Option Exercise$1.2428,00034,720140,117Mar 12, 2024, 05:29 PM
Boyce SarahPresident and CEOMar 12, 2024 Sale$22.6328,000633,682112,117Mar 12, 2024, 05:29 PM
Boyce SarahPresident and CEOMar 08, 2024 Sale$21.3984,0001,796,710112,117Mar 12, 2024, 05:29 PM
Boyce SarahPresident and CEOMar 01, 2024 Option Exercise$1.2484,000104,160196,117Mar 05, 2024, 04:53 PM
Boyce SarahPresident and CEOMar 01, 2024 Sale$20.1384,0001,691,306112,117Mar 05, 2024, 04:53 PM
LEVIN ARTHUR ADirectorJan 22, 2024 Sale$10.131,85918,83217,471Jan 23, 2024, 03:14 PM
Boyce SarahPresident and CEOJan 22, 2024 Sale$10.135,09251,58244,008Jan 23, 2024, 03:13 PM
Flanagan W. MichaelCSTOJan 22, 2024 Sale$10.134,12941,82735,871Jan 23, 2024, 03:12 PM
McCarthy TeresaChief Human Resources OfficerJan 22, 2024 Sale$10.132,06520,91817,035Jan 23, 2024, 03:11 PM
MacLean Michael FChief Financial OfficerJan 22, 2024 Sale$10.131,61616,37016,884Jan 23, 2024, 03:11 PM
LEVIN ARTHUR ADirectorMar 15, 2023 Option Exercise$1.2410012419,430Mar 17, 2023, 04:36 PM
LEVIN ARTHUR ADirectorMar 15, 2023 Sale$22.011002,20119,330Mar 17, 2023, 04:36 PM
LEVIN ARTHUR AChief Scientific OfficerFeb 14, 2023 Option Exercise$1.2410,00012,40029,330Feb 15, 2023, 08:30 PM
LEVIN ARTHUR AChief Scientific OfficerFeb 14, 2023 Sale$23.6610,000236,56719,853Feb 15, 2023, 08:30 PM
Boyce SarahPresident and CEOFeb 03, 2023 Option Exercise$1.243,2213,99456,573Feb 03, 2023, 05:26 PM
Boyce SarahPresident and CEOFeb 02, 2023 Option Exercise$1.2445,87956,89099,231Feb 03, 2023, 05:26 PM
Boyce SarahPresident and CEOFeb 01, 2023 Option Exercise$1.249001,11654,252Feb 03, 2023, 05:26 PM
Boyce SarahPresident and CEOFeb 02, 2023 Sale$24.3645,8791,117,74153,352Feb 03, 2023, 05:26 PM
Boyce SarahPresident and CEOFeb 01, 2023 Sale$24.2790021,84453,352Feb 03, 2023, 05:26 PM
Boyce SarahPresident and CEOFeb 03, 2023 Sale$24.263,22178,14153,352Feb 03, 2023, 05:26 PM
LEVIN ARTHUR AChief Scientific OfficerJan 12, 2023 Option Exercise$1.2410,00012,40011,330Jan 17, 2023, 08:50 PM
LEVIN ARTHUR AChief Scientific OfficerJan 12, 2023 Sale$22.0010,000220,0281,330Jan 17, 2023, 08:50 PM
LEVIN ARTHUR AChief Scientific OfficerDec 29, 2022 Option Exercise$1.2440,00049,60041,330Jan 03, 2023, 05:40 PM
LEVIN ARTHUR AChief Scientific OfficerDec 29, 2022 Sale$22.0140,000880,5681,330Jan 03, 2023, 05:40 PM
LEVIN ARTHUR AChief Scientific OfficerAug 12, 2022 Option Exercise$0.5314,0037,42215,333Aug 31, 2022, 08:08 PM
LEVIN ARTHUR AChief Scientific OfficerAug 16, 2022 Option Exercise$1.243,4994,3394,829Aug 31, 2022, 08:08 PM
LEVIN ARTHUR AChief Scientific OfficerAug 15, 2022 Option Exercise$0.9262,49857,80263,828Aug 31, 2022, 08:08 PM
LEVIN ARTHUR AChief Scientific OfficerAug 12, 2022 Sale$22.0014,003308,0661,330Aug 31, 2022, 08:08 PM
LEVIN ARTHUR AChief Scientific OfficerAug 16, 2022 Sale$22.083,49977,2571,330Aug 31, 2022, 08:08 PM
LEVIN ARTHUR AChief Scientific OfficerAug 15, 2022 Sale$22.1262,4981,382,3431,330Aug 31, 2022, 08:08 PM
Boyce SarahPresident and CEOAug 25, 2022 Option Exercise$1.2414,85518,42014,855Aug 26, 2022, 07:29 PM
Boyce SarahPresident and CEOAug 24, 2022 Option Exercise$1.2435,04543,45635,045Aug 26, 2022, 07:29 PM
Boyce SarahPresident and CEOAug 25, 2022 Sale$23.0714,855342,6900Aug 26, 2022, 07:29 PM
Boyce SarahPresident and CEOAug 24, 2022 Sale$22.8035,045798,9240Aug 26, 2022, 07:29 PM
Boyce SarahPresident and CEOAug 15, 2022 Option Exercise$1.24100124100Aug 17, 2022, 09:40 PM
Boyce SarahPresident and CEOAug 15, 2022 Sale$22.471002,2470Aug 17, 2022, 09:40 PM
LEVIN ARTHUR AChief Scientific OfficerNov 18, 2021 Option Exercise$1.2225,00030,57126,330Nov 22, 2021, 08:22 PM
LEVIN ARTHUR AChief Scientific OfficerNov 18, 2021 Sale$27.8925,000697,2181,330Nov 22, 2021, 08:22 PM
RTW INVESTMENTS, LP10% OwnerAug 04, 2021 Buy$18.00800,00014,400,0004,795,000Aug 06, 2021, 11:20 AM
LEVIN ARTHUR AChief Scientific OfficerJun 24, 2021 Option Exercise$1.241001241,430Jun 28, 2021, 07:21 PM
LEVIN ARTHUR AChief Scientific OfficerJun 25, 2021 Option Exercise$1.1320,10022,73521,430Jun 28, 2021, 07:21 PM
LEVIN ARTHUR AChief Scientific OfficerJun 24, 2021 Sale$27.751002,7751,330Jun 28, 2021, 07:21 PM
LEVIN ARTHUR AChief Scientific OfficerJun 25, 2021 Sale$28.1220,100565,2993,977Jun 28, 2021, 07:21 PM
LEVIN ARTHUR AChief Scientific OfficerJun 17, 2021 Option Exercise$1.242002481,530Jun 22, 2021, 08:24 PM
LEVIN ARTHUR AChief Scientific OfficerJun 17, 2021 Sale$27.752005,5501,330Jun 22, 2021, 08:24 PM
LEVIN ARTHUR AChief Scientific OfficerJun 15, 2021 Sale$26.0223,019599,0670Jun 16, 2021, 08:21 PM
LEVIN ARTHUR AChief Scientific OfficerJun 14, 2021 Sale$25.9214,003362,92123,019Jun 16, 2021, 08:21 PM
LEVIN ARTHUR AChief Scientific OfficerMar 16, 2021 Option Exercise$0.944,6004,3024,600Mar 18, 2021, 09:39 PM
LEVIN ARTHUR AChief Scientific OfficerMar 16, 2021 Sale$27.874,600128,1810Mar 18, 2021, 09:39 PM
Cormorant Asset Management, LPFormer 10% OwnerJun 16, 2020 Buy$18.00300,0005,400,0002,514,545Jun 18, 2020, 04:02 PM
RTW INVESTMENTS, LP10% OwnerJun 16, 2020 Buy$18.00950,00017,100,0003,995,000Jun 16, 2020, 04:28 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Boyce SarahPresident and CEO06/04/202434,720
Boyce SarahPresident and CEO06/04/2024767,780
LEVIN ARTHUR ADirector05/20/20246,200
LEVIN ARTHUR ADirector05/20/2024149,481
MacLean Michael FChief Financial Officer05/14/2024661,500
MacLean Michael FChief Financial Officer05/14/20242,121,045
Boyce SarahPresident and CEO05/07/202434,720
Boyce SarahPresident and CEO05/07/2024715,050
LEVIN ARTHUR ADirector04/19/20246,200
LEVIN ARTHUR ADirector04/19/2024114,123
LEVIN ARTHUR ADirector04/03/2024542,214
Boyce SarahPresident and CEO04/02/202434,720
Boyce SarahPresident and CEO04/02/2024734,919
LEVIN ARTHUR ADirector03/19/20246,200
LEVIN ARTHUR ADirector03/19/2024119,847
MacLean Michael FChief Financial Officer03/13/2024352,800
MacLean Michael FChief Financial Officer03/13/2024980,760
LEVIN ARTHUR ADirector03/12/202431,000
LEVIN ARTHUR ADirector03/12/2024609,017
Boyce SarahPresident and CEO03/08/2024104,160
Boyce SarahPresident and CEO03/12/202434,720
Boyce SarahPresident and CEO03/12/2024633,682
Boyce SarahPresident and CEO03/08/20241,796,710
Boyce SarahPresident and CEO03/01/2024104,160
Boyce SarahPresident and CEO03/01/20241,691,306
LEVIN ARTHUR ADirector01/22/202418,832
Boyce SarahPresident and CEO01/22/202451,582
Flanagan W. MichaelCSTO01/22/202441,827
McCarthy TeresaChief Human Resources Officer01/22/202420,918
MacLean Michael FChief Financial Officer01/22/202416,370
LEVIN ARTHUR ADirector03/15/2023124
LEVIN ARTHUR ADirector03/15/20232,201
LEVIN ARTHUR AChief Scientific Officer02/14/202312,400
LEVIN ARTHUR AChief Scientific Officer02/14/2023236,567
Boyce SarahPresident and CEO02/03/20233,994
Boyce SarahPresident and CEO02/02/202356,890
Boyce SarahPresident and CEO02/01/20231,116
Boyce SarahPresident and CEO02/02/20231,117,741
Boyce SarahPresident and CEO02/01/202321,844
Boyce SarahPresident and CEO02/03/202378,141
LEVIN ARTHUR AChief Scientific Officer01/12/202312,400
LEVIN ARTHUR AChief Scientific Officer01/12/2023220,028
LEVIN ARTHUR AChief Scientific Officer12/29/202249,600
LEVIN ARTHUR AChief Scientific Officer12/29/2022880,568
LEVIN ARTHUR AChief Scientific Officer08/12/20227,422
LEVIN ARTHUR AChief Scientific Officer08/16/20224,339
LEVIN ARTHUR AChief Scientific Officer08/15/202257,802
LEVIN ARTHUR AChief Scientific Officer08/12/2022308,066
LEVIN ARTHUR AChief Scientific Officer08/16/202277,257
LEVIN ARTHUR AChief Scientific Officer08/15/20221,382,343
Boyce SarahPresident and CEO08/25/202218,420
Boyce SarahPresident and CEO08/24/202243,456
Boyce SarahPresident and CEO08/25/2022342,690
Boyce SarahPresident and CEO08/24/2022798,924
Boyce SarahPresident and CEO08/15/2022124
Boyce SarahPresident and CEO08/15/20222,247
LEVIN ARTHUR AChief Scientific Officer11/18/202130,571
LEVIN ARTHUR AChief Scientific Officer11/18/2021697,218
RTW INVESTMENTS, LP10% Owner08/04/202114,400,000
LEVIN ARTHUR AChief Scientific Officer06/24/2021124
LEVIN ARTHUR AChief Scientific Officer06/25/202122,735
LEVIN ARTHUR AChief Scientific Officer06/24/20212,775
LEVIN ARTHUR AChief Scientific Officer06/25/2021565,299
LEVIN ARTHUR AChief Scientific Officer06/17/2021248
LEVIN ARTHUR AChief Scientific Officer06/17/20215,550
LEVIN ARTHUR AChief Scientific Officer06/15/2021599,067
LEVIN ARTHUR AChief Scientific Officer06/14/2021362,921
LEVIN ARTHUR AChief Scientific Officer03/16/20214,302
LEVIN ARTHUR AChief Scientific Officer03/16/2021128,181
Cormorant Asset Management, LPFormer 10% Owner06/16/20205,400,000
RTW INVESTMENTS, LP10% Owner06/16/202017,100,000
Load More Insider Transactions
FUNDS WITH A POSITION IN AVIDITY BIOSCIENCES INC
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
BLACKROCK INC.6,165,9910.00366%-5.09%Other
RA CAPITAL MANAGEMENT, L.P.4,895,9591.52%49.17%Other
ADAGE CAPITAL PARTNERS GP, L.L.C.2,400,0450.12%50%Other
GEODE CAPITAL MANAGEMENT, LLC1,599,6740.00378%3.39%Other
BALYASNY ASSET MANAGEMENT L.P.51,0550.00228%-95.8%Event Driven
ORBIMED ADVISORS LLC994,1000.46%NewOther
FARALLON CAPITAL MANAGEMENT LLC606,0610.07%NewEvent Driven, Value
CANDRIAM S.C.A.290,0670.02%ExitedOther
RENAISSANCE TECHNOLOGIES LLC226,7000.00318%ExitedOther
TUDOR INVESTMENT CORP ET AL68,8870.01%NewEvent Driven, Other
ALPS ADVISORS INC56,2270.01%10.96%Other
D. E. SHAW & CO., INC.31,2660.00068%-24.63%Other
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)18,7080.00313%ExitedOther
CHANGE IN SHARES OUTSTANDING FOR AVIDITY BIOSCIENCES INC
STOCK BUYBACKS FOR AVIDITY BIOSCIENCES INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
03/31/2024
12/31/2023
14.62%
1Q
03/31/2024
09/30/2023
17.70%
2Q
03/31/2024
06/30/2023
22.16%
3Q
03/31/2024
03/31/2023
23.82%
4Q
03/31/2024
12/31/2022
52.06%
5Q
03/31/2024
09/30/2022
64.34%
6Q
03/31/2024
06/30/2022
74.68%
7Q
03/31/2024
03/31/2022
80.77%
8Q
03/31/2024
12/31/2021
84.45%
9Q
Load More

Period of Report: 03/31/2024

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
12/31/2023
14.62%
1Q
09/30/2023
17.70%
2Q
06/30/2023
22.16%
3Q
03/31/2023
23.82%
4Q
12/31/2022
52.06%
5Q
09/30/2022
64.34%
6Q
06/30/2022
74.68%
7Q
03/31/2022
80.77%
8Q
12/31/2021
84.45%
9Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR AVIDITY BIOSCIENCES INC
LOADING...